OSR Holdings (formerly known as Bellevue Life Sciences Acquisition) is a company focused on healthcare innovation. It focuses on oral T-cell mediated immunotherapies, disease-modifying osteoarthritis drugs (DMOAD), and noninvasive glucose monitoring (CGM) solutions. The company serves the immunotherapy, regenerative medicine, and medical device sectors.